Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
BMC Research Notes|April 19, 2015
Intramedullary spinal cord metastasis of cholangiocarcinoma: a case reportLaurence Faugeras, Gaetan Cantineau, Jean-Francois Daisne, et al.Therapeutic Advances in Medical Oncology|February 6, 2018
Refractory thyroid carcinoma: which systemic treatment to use?Laurence Faugeras, Anne-Sophie Pirson, Julian Donckier, et al.European Journal of Case Reports in Internal Medicine|July 10, 2025
<sup>18</sup>FDG PET/CT is Sensitive but not Specific for Malignancy: Two Cases of Disseminated Tuberculosis Mimicking Metastatic Cancer on Imaging and Clinical PresentationMaxime Collin, Bruno Krug, Marie-Cécile Nollevaux, et al.Case Reports in Oncology|June 28, 2021
Eccrine Porocarcinoma: A Challenging Diagnostic and Therapeutic Tumoral EntityHa Mo Linh Le, Laurence Faugeras, Véronique De Moor, et al.Head & Neck|February 25, 2023
Aggressive recurrent respiratory papillomatosis: A series of five consecutive patients successfully treated with adjuvant intravenous bevacizumab. A single Belgian academic center experienceFanny Collette, Georges Lawson, Samantha Hassid, et al.Case Reports in Oncology|December 28, 2017
Recurrent Masses after Testicular Cancer: Growing Teratoma Syndrome. A Case Report and Review of the LiteratureFanny Priod, Francis Lorge, Marcelo Di Gregorio, et al.Journal of Gastrointestinal Cancer|September 28, 2020
Incidence and Prognosis of Biliary Tract and Gallbladder Cancers in a Belgian Academic HospitalQuentin Gilliaux, Laurence Faugeras, Jean-Paul Martinet, et al.Current Protocols|December 7, 2023
Budget-Friendly Generation, Biochemical Analyses, and Lentiviral Transduction of Patient-Derived Colon OrganoidsEmilie Rigaux, Jia-Wei Chen, Fabienne George, et al.Clinical Epigenetics|May 19, 2017
Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancerJean-François Rahier, Anne Druez, Laurence Faugeras, et al.Lancet (London, England)|June 18, 2023
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 studyArvind Dasari, Sara Lonardi, Rocio Garcia-Carbonero, et al.Pageof 2